NFG
TTPH

Next Financial Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Next Financial Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11
Closed -$2K – 1607
2017
Q3 		$2K Hold
11
– – ﹤0.01% 1647
2017
Q2 		$2K Hold
11
– – ﹤0.01% 1782
2017
Q1 		$2K Sell
11
-60
-85% -$6.73K ﹤0.01% 1753
2016
Q4 		$6K Buy
71
+60
+545% +$4.75K ﹤0.01% 1887
2016
Q3 		$1K Buy
+11
New +$881 ﹤0.01% 2332

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Next Financial Group's TTPH Position: Q4 2017 in Review

Next Financial Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2017, closing a stake of 11 shares — an estimated $2K sold.

Next Financial Group first reported a position in TTPH in Q3 2016 and held it in 5 quarters. The position peaked at $6K in Q4 2016. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

  • Next Financial Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Next Financial Group sold 11 Tetraphase Pharmaceuticals, Inc. shares in Q4 2017, an estimated $2K.
  • Next Financial Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2016 and held it in 5 quarters.
  • Next Financial Group's Tetraphase Pharmaceuticals, Inc. position peaked at $6K in Q4 2016.
  • 103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on Next Financial Group's 13F filing for Q4 2017, filed 16 Jan 2018.